Zobrazeno 1 - 10
of 2 804
pro vyhledávání: '"copd exacerbations"'
Autor:
Evans A, Tarabichi Y, Pace WD, Make B, Bushell N, Carter V, Chang KL, Fox C, Han MK, Kaplan A, Kocks JWH, Le Lievre C, Roussos A, Skolnik N, Soriano JB, Yawn BP, Price D
Publikováno v:
Pragmatic and Observational Research, Vol Volume 15, Pp 221-232 (2024)
Alexander Evans,1 Yasir Tarabichi,2 Wilson D Pace,3,4 Barry Make,5 Nicholas Bushell,6 Victoria Carter,7 Ku-Lang Chang,8 Chester Fox,9 MeiLan K Han,10 Alan Kaplan,11,12 Janwillem WH Kocks,13– 15 Chantal Le Lievre,6 Alexander Roussos,6 Neil Skolnik,1
Externí odkaz:
https://doaj.org/article/6f00040fcd7e428e8be7a9d96bc0caad
Autor:
Heerfordt CK, Rønn C, Eklöf J, Sivapalan P, Harboe ZB, Hyldgaard C, Fløe A, Mathioudakis AG, Lassen MCH, Biering-Sørensen T, Jensen JUS
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 2169-2179 (2024)
Christian Kjer Heerfordt,1 Christian Rønn,1 Josefin Eklöf,1 Pradeesh Sivapalan,1 Zitta Barrella Harboe,2,3 Charlotte Hyldgaard,4 Andreas Fløe,5 Alexander G Mathioudakis,6,7 Mats Christian Højbjerg Lassen,8 Tor Biering-Sørensen,8,9 Jens-Ulrik St
Externí odkaz:
https://doaj.org/article/5efc8d209ec84b06b16e16b3fb08ed86
Autor:
Charles-Antoine Guay, François Maltais, Claudia Beaudoin, Pierre-Hugues Carmichael, Elhadji Anassour Laouan Sidi, Laurie Perreault, Caroline Sirois, Steeve Provencher
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Little is known about the trends in morbidity and mortality at the population level that followed the introduction of newer once-daily long-acting bronchodilators for COPD. The purpose of the study was to evaluate whether the avai
Externí odkaz:
https://doaj.org/article/3ed1ed0b2420412aa92d4f54504391b4
Autor:
Federica Baffetta, Cecilia Buonsanti, Luca Moraschini, Susanna Aprea, Martina Canè, Stefano Lombardi, Mario Contorni, Simona Rondini, Ashwani Kumar Arora, Monia Bardelli, Oretta Finco, Davide Serruto, Silvia Rossi Paccani
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTChronic obstructive pulmonary disease (COPD) is a common chronic respiratory illness in older adults. A major cause of COPD-related morbidity and mortality is acute exacerbation of COPD (AECOPD). Bacteria in the lungs play a role in exacerbat
Externí odkaz:
https://doaj.org/article/7a07accd746d495fba2002009df440b6
Autor:
Dhand, Rajiv a, b, ∗, Treat, Samuel a, b, Ferris, Jennifer b, Terry, Paul D. b, Walker, Tracy b, Elder, Scott c, Church, Daniel c, Dennis, Danielle c, Faircloth, Barbara c, Onar, Gulsah b, Heidel, R. Eric d, Biney, Isaac a, Valdes, Martin b, Bhagat, Milind a, Fuerst, Nicholas a, Cusick, Shannon e
Publikováno v:
In CHEST Pulmonary December 2024 2(4)
Publikováno v:
COPD, Vol 20, Iss 1, Pp 292-297 (2023)
During the COVID-19 pandemic the number of hospital admissions due to chronic obstructive pulmonary disease (COPD) exacerbations was significantly reduced. The reason for this decline is not fully understood. Governmental non-pharmaceutical intervent
Externí odkaz:
https://doaj.org/article/f9b2ebb2ddb146d3be63a34841d35e30
Autor:
Miravitlles M, Acharya S, Aggarwal B, Fernandes FL, Dreyse J, Jardim JR, Juthong S, Levy G, Sivori M
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 1853-1866 (2023)
Marc Miravitlles,1 Sudeep Acharya,2 Bhumika Aggarwal,2 Frederico LA Fernandes,3 Jorge Dreyse,4 José R Jardim,5 Siwasak Juthong,6 Gur Levy,7 Martin Sivori8 1Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Rece
Externí odkaz:
https://doaj.org/article/d3c45a9c50b8447ba823929ca471f701
Autor:
Althobiani MA, Khan B, Shah AJ, Ranjan Y, Mendes RG, Folarin A, Mandal S, Porter JC, Hurst JR
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 1401-1412 (2023)
Malik A Althobiani,1,2 Bilal Khan,1 Amar J Shah,1,3 Yatharth Ranjan,4 Renata G Mendes,1,5 Amos Folarin,4 Swapna Mandal,1,3 Joanna C Porter,1,6 John R Hurst1,3 1UCL Respiratory, University College London, London, UK; 2Department of Respiratory Therapy
Externí odkaz:
https://doaj.org/article/384bc614c9ef413fbf8cf29a7905e3c2
Publikováno v:
COPD, Vol 19, Iss 1, Pp 133-141 (2022)
Recent reports provide evidence-based guidelines for the withdrawal of inhaled corticosteroids (ICS) in COPD, but data on patients treated with ICS-based triple therapy are sparse and contradictory. We assessed the effect of ICS discontinuation on th
Externí odkaz:
https://doaj.org/article/6bcddb770142485dbf7c8c784bef684f
Publikováno v:
COPD, Vol 19, Iss 1, Pp 109-117 (2022)
Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We compared budesonide-based and fluticasone-based triple therapy given in
Externí odkaz:
https://doaj.org/article/a51b0fe1a618414caf0e7e7bfc59de41